MedTrace Logo

Intermittent Preventive Treatment for Malaria in Infants in Navrongo Ghana

NCT00857077 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2485

Last updated 2017-01-26

No results posted yet for this study

Summary

Evaluation of the safety and effectiveness of malaria intermittent chemotherapy and iron supplementation delivered through Expanded Programme on Immunisation vaccination clinics.

Conditions

Interventions

DRUG

Sulfadoxine-pyrimethamine

DRUG

Placebo

Sponsors & Collaborators

  • Navrongo Health Research Centre, Navrongo, Ghana.

    collaborator UNKNOWN

  • Kintampo Health Research Centre, Ghana

    collaborator OTHER

  • INDEPTH Network

    collaborator OTHER

  • Department for International Development, United Kingdom

    collaborator OTHER_GOV

  • London School of Hygiene and Tropical Medicine

    lead OTHER

Principal Investigators

  • Daniel Chandramohan, MD; PhD · London School of Hygiene and Tropical Medicine

  • Brian Greenwood, MD · London School of Hygiene and Tropical Medicine

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
2 Months
Max Age
24 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2000-09-30
Completion
2004-06-30

Countries

  • Ghana

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00857077 on ClinicalTrials.gov